These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

88 related items for PubMed ID: 1700858

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Lack of seasonal variation in pediatric lumbar cerebrospinal fluid neurotransmitter metabolite concentrations.
    Swedo SE, Kruesi MJ, Leonard HL, Hamburger SD, Cheslow DL, Stipetic M, Potter WZ.
    Acta Psychiatr Scand; 1989 Dec; 80(6):644-9. PubMed ID: 2482656
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Changes in cerebrospinal fluid neurochemistry during treatment of obsessive-compulsive disorder with clomipramine.
    Altemus M, Swedo SE, Leonard HL, Richter D, Rubinow DR, Potter WZ, Rapoport JL.
    Arch Gen Psychiatry; 1994 Oct; 51(10):794-803. PubMed ID: 7524463
    [Abstract] [Full Text] [Related]

  • 6. A 2-year prospective follow-up study of children and adolescents with disruptive behavior disorders. Prediction by cerebrospinal fluid 5-hydroxyindoleacetic acid, homovanillic acid, and autonomic measures?
    Kruesi MJ, Hibbs ED, Zahn TP, Keysor CS, Hamburger SD, Bartko JJ, Rapoport JL.
    Arch Gen Psychiatry; 1992 Jun; 49(6):429-35. PubMed ID: 1376104
    [Abstract] [Full Text] [Related]

  • 7. CSF somatostatin in obsessive-compulsive disorder.
    Altemus M, Pigott T, L'Heureux F, Davis CL, Rubinow DR, Murphy DL, Gold PW.
    Am J Psychiatry; 1993 Mar; 150(3):460-4. PubMed ID: 8094599
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A naturalistic exploratory study of the impact of demographic, phenotypic and comorbid features in pediatric obsessive-compulsive disorder.
    Masi G, Millepiedi S, Perugi G, Pfanner C, Berloffa S, Pari C, Mucci M, Akiskal HS.
    Psychopathology; 2010 Mar; 43(2):69-78. PubMed ID: 20068377
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Autonomic activity in relation to cerebrospinal fluid neurochemistry in obsessive and disruptive children and adolescents.
    Zahn TP, Kruesi MJ, Swedo SE, Leonard HL, Rapoport JL.
    Psychophysiology; 1996 Nov; 33(6):731-9. PubMed ID: 8961795
    [Abstract] [Full Text] [Related]

  • 14. Clinical Correlates of Hoarding With and Without Comorbid Obsessive-Compulsive Symptoms in a Community Pediatric Sample.
    Burton CL, Crosbie J, Dupuis A, Mathews CA, Soreni N, Schachar R, Arnold PD.
    J Am Acad Child Adolesc Psychiatry; 2016 Feb; 55(2):114-21.e2. PubMed ID: 26802778
    [Abstract] [Full Text] [Related]

  • 15. Cortisol in the CSF of depressed and suicidal patients.
    Träskman L, Tybring G, Asberg M, Bertilsson L, Lantto O, Schalling D.
    Arch Gen Psychiatry; 1980 Jul; 37(7):761-7. PubMed ID: 6156664
    [Abstract] [Full Text] [Related]

  • 16. Elevated cerebrospinal fluid levels of oxytocin in obsessive-compulsive disorder. Comparison with Tourette's syndrome and healthy controls.
    Leckman JF, Goodman WK, North WG, Chappell PB, Price LH, Pauls DL, Anderson GM, Riddle MA, McSwiggan-Hardin M, McDougle CJ.
    Arch Gen Psychiatry; 1994 Oct; 51(10):782-92. PubMed ID: 7524462
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.